IL17RA and in situ carcinoma: The association of Il17ra/IL17RA with monophasic-EAE incidence is plausible, given the involvement of IL-17 and Th17 cells in MS/EAE pathogenesis (57, 58), particularly CIS and early MS (59, 60).